Philina Lee - 13 Dec 2023 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Melissa Masse
Issuer symbol
BPMC
Transactions as of
13 Dec 2023
Net transactions value
+$488
Form type
4
Filing time
14 Feb 2024, 18:54:55 UTC
Previous filing
14 Jun 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $488 +261 +0.84% $1.87* 31,439 13 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -261 -100% $0.000000* 0 13 Dec 2023 Common Stock 261 $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on August 18, 2014 and are fully vested as of the transaction date.